Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Phathom Pharmaceuticals Inc (NQ: PHAT )

6.190 -0.090 (-1.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 380,042
Open 6.210
Bid (Size) 6.000 (50)
Ask (Size) 8.300 (4)
Prev. Close 6.280
Today's Range 5.840 - 6.220
52wk Range 5.840 - 16.07
Shares Outstanding 41,973,271
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Friday
  On Friday, 469 companies hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
 
Via Benzinga

Performance

YTD
-48.37%
-48.37%
1 Month
-37.79%
-37.79%
3 Month
-39.31%
-39.31%
6 Month
-36.84%
-36.84%
1 Year
-53.25%
-53.25%

More News

Read More
Where Phathom Pharmaceuticals Stands With Analysts
Via Benzinga
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
From The Rosen Law Firm PA
Via Globe NewsWire
Where Phathom Pharmaceuticals Stands With Analysts
Via Benzinga
Phathom Pharma Shares Fall After Formal FDA Request For Vonoprazan Data
Via Benzinga
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
Via NewMediaWire
Exposures Product Safety
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
Via NewMediaWire
Exposures Product Safety
TOP RANKED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
From The Rosen Law Firm, P.A.
Via Business Wire
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Phathom Pharmaceuticals
Via Globe NewsWire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
Via NewMediaWire
Exposures Product Safety
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
Via NewMediaWire
Exposures Product Safety
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Investor Alert: Investigation over Potential Wrongdoing
Via SBWire
$14M Bet On This Technology Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
From The Rosen Law Firm PA
Via Globe NewsWire
Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
One Analyst Is Bullish While Another Sees Overhang On Phathom Pharma Stock After Two Rejection Letters
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Phathom Pharmaceuticals Provides Regulatory Updates
From Phathom Pharmaceuticals
Via Globe NewsWire
TOP RANKED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
From The Rosen Law Firm PA
Via Globe NewsWire
Bragar Eagel & Squire, P.C. Is Investigating Credit Acceptance, and Phathom and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Why Shares of Phathom Pharmaceutical Jumped This Week
Via The Motley Fool
Seagate, Boot Barn, Tesla And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.